Eric Venker, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 3,092 shares at $38.48 ($119K) on 2026-07-02, disclosed to the SEC on 2026-07-06.
Open-market sale of $119k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| ROIV | SELL | 2026-06-26 | $6.6M | — | Filing → |